Efficacy and safety of colonic stenting for malignant disease in the elderly

Self-expandable metal stents (SEMS) are an accepted palliation for malignant colorectal obstruction. Outcomes of stent insertion solely in older patients are unknown. To compare outcomes of SEMS insertion for malignant colorectal disease, in older versus younger patients. Forty-three patients were retrospectively identified as having undergone SEMS insertion for obstructing colorectal cancer. Of these, 24 were a parts per thousand yenaEuro parts per thousand 70 years of age (older patient group) and 19 were < 70 years of age (younger patient group). There was no significant difference in successful SEMS insertion between the groups (88% in older versus 100% in younger patients, p > 0.05). Furthermore, the complication rate was similar in both groups (12.5% versus 26%, p > 0.10). There was no difference in median survival (113 days versus 135 days, p > 0.09). Colorectal stenting for malignant disease in older patients is both safe and effective with comparative success and complication rates to a younger population.